Study of the Safety and Effectiveness of the Artificial Cervical Disc - Low Profile Device at Two Adjacent Levels

Radiculopathy Clinical Trial

Official title:

A Prospective, Randomized, Controlled, Multicenter Pivotal Clinical Trial of the Artificial Cervical Disc-LP at Two Levels for Symptomatic Cervical Disc Disease

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00637156
• Other study ID #: PRESTIGE LP Two Level Study
• Status: Completed
• Phase: N/A
• Start date: June 2006
• Est. completion date: February 1, 2018

Study information

• Verified date: October 2017
• Source: Medtronic Spinal and Biologics
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this clinical investigation is to assess the safety and effectiveness of using the PRESTIGE-LP device in the treatment of patients with symptomatic degenerative disc disease at two adjacent levels of the cervical spine, with overall success being the primary endpoint of the clinical trial. The primary objective is to show non-inferiority of the investigational device to the control treatment. If non-inferiority is established, superiority will also be examined as the secondary objective.

Description:

This clinical investigation is being conducted to evaluate the PRESTIGE-LP device's performance at two adjacent cervical levels (C3-C7) in the treatment of patients with symptomatic degenerative disc disease. One-half of the patients in this randomized pivotal clinical trial will be treated at two adjacent cervical levels with the PRESTIGE-LP device. The remaining patients will receive a bi-level anterior cervical discectomy and fusion with cortical ring allografts and the ATLANTIS Cervical Plate System.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 397
• Est. completion date: February 1, 2018
• Est. primary completion date: January 2011
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Has cervical DDD at 2 adjacent cervical levels (C3-C7) requiring surgical treatment & involving intractable radiculopathy, myelopathy, or both

• Has a herniated disc and/or osteophyte formation at each level to be treated that is producing symptomatic nerve root and/or spinal cord compression. The condition is documented by patient history, and the requirement for surgical treatment is evidenced by radiographic studies

• Unresponsive to non-operative treatment for approximately 6 weeks or has the presence of progressive symptoms or signs of nerve root/spinal cord compression in the face of continued non-operative management

• Has no previous surgical intervention at the involved levels or any subsequent planned/staged surgical procedure at the involved or adjacent level(s)

• Must be = 18 years; skeletally mature at time of surgery

• Preoperative NDI score = 30

• Preoperative neck pain score = 8 based on the preoperative Neck and Arm Pain Questionnaire

• If a female of childbearing potential, patient is non-pregnant, non-nursing, and agrees not to become pregnant during the study period

• Is willing to comply with the study plan and sign Patient Informed Consent Form

Exclusion Criteria:

• Has a cervical spinal condition other than symptomatic cervical DDD requiring surgical treatment at the involved levels

• Has documented or diagnosed cervical instability relative to adjacent segments at either level, defined by dynamic (flexion/extension) radiographs showing: Sagittal plane translation > 3.5 mm, or Sagittal plane angulation > 20 degrees.

• Has more than two cervical levels requiring surgical treatment

• Has a fused level adjacent to the levels to be treated

• Has severe pathology of the facet joints of the involved vertebral bodies

• Has had previous surgical intervention at either one or both of the involved levels or at adjacent levels

• Has been previously diagnosed with osteopenia or osteomalacia

• Has any of the following that may be associated with a diagnosis of osteoporosis (If "Yes" to any of the below a DEXA Scan will be required to determine eligibility.)

• Postmenopausal non-Black female over age of 60 who weighs < 140 pounds

• Postmenopausal female who has sustained a non-traumatic hip, spine, or wrist fracture

• Male > 70 years

• Male > 60 years who has sustained a non-traumatic hip or spine fracture

• If the level of BMD is a T score of -3.5 or lower or a T score of -2.5 or lower with vertebral crush fracture, then the patient is excluded from the study

• Has presence of spinal metastases

• Has overt or active bacterial infection, either local or systemic

• Has insulin dependent diabetes

• Is a tobacco user who does not agree to suspend smoking prior to surgery

• Has chronic or acute renal failure or prior history of renal disease

• Has a documented allergy or intolerance to stainless steel, titanium, or a titanium alloy

• Is mentally incompetent (If questionable, obtain psychiatric consult)

• Is a prisoner

• Is pregnant

• Is an alcohol and/or drug abuser as defined by currently undergoing treatment for alcohol and/or drug abuse

• Is involved with current or pending litigation regarding a spinal condition

• Has received drugs that may interfere with bone metabolism within two weeks prior to the planned date of spinal surgery (e.g., steroids or methotrexate), excluding routine perioperative anti-inflammatory drugs

• Has a history of an endocrine or metabolic disorder known to affect osteogenesis (e.g., Paget's Disease, renal osteodystrophy, Ehlers-Danlos Syndrome, or osteogenesis imperfecta)

• Has a condition that requires postoperative medications that interfere with the stability of the implant, such as steroids. (This does not include low-dose aspirin for prophylactic anticoagulation and routine perioperative anti-inflammatory drugs.)

• Has received treatment with an investigational therapy within 28 days prior to implantation surgery or such treatment is planned during the 16 weeks following implantation

Related Conditions & MeSH terms

• Cervical Degenerative Disc Disease
• Intervertebral Disc Degeneration
• Myelopathy
• Radiculopathy
• Spinal Cord Diseases

Intervention

Device:
• PRESTIGE LP device at two adjacent levels
PRESTIGE LP is a prosthetic device intended to replace a damaged disc in the cervical spine and intended to act as an intervertebral body spacer rather than a fusion device. It is inserted using an anterior surgical approach.
• Bi-level fusion with ATLANTIS Cervical Plate System
Bi-level anterior cervical fusion procedure involving cortical ring allograft and the ATLANTIS Cervical Plate System.

Locations

Country	Name	City	State
United States	Crystal Clinic, Inc.; Akron General Medical Center	Akron	Ohio
United States	OAA Orthopaedic Specialists	Allentown	Pennsylvania
United States	Peachtree Neurosurgery, Northside Hospital	Atlanta	Georgia
United States	Central Texas Spine Institute; Health South Surgical Center	Austin	Texas
United States	The Center Orthopaedic & Neurosurgical Care & Research	Bend	Oregon
United States	Todd Lanman, MD, FACS, A Professional Corp.;	Beverly Hills	California
United States	University at Buffalo Neurosurgery, Inc. Kaleida Health-Buffalo General Medical center/Gates Vascular Institute	Buffalo	New York
United States	Center for Sports Medicine and Orthopaedics; Memorial Hospital	Chattanooga	Tennessee
United States	The Orthopedic Center of St. Louis; Barnes Jewish West County Hospital	Chesterfield	Missouri
United States	Bone & Spine Surgery	Colton	California
United States	The Hughston Clinic, P.C., Hughston Hospital and Rehabilitation Center	Columbus	Georgia
United States	Neuro Spine & Pain Center; Lutheran Hospital	Fort Wayne	Indiana
United States	Great Lakes Neurosurgical; Spectrum Health East Campus	Grand Rapids	Michigan
United States	The Orthopaedic Center; Crestwood Medical Center	Huntsville	Alabama
United States	University of Iowa Hospitals & Clinics	Iowa City	Iowa
United States	East Tennessee Brain & Spine Center, Johnson City Medical Center	Johnson City	Tennessee
United States	La Jolla Neurological Associates, AMC; Scripps Memorial Hospital La Jolla; Scripps Memorial Hospital Encinitas	La Jolla	California
United States	Montana Neuro Science Institute; St. Patrick's Medical Center	Missoula	Montana
United States	West Virginia University; Ruby Memorial Hospital, WVU Hospitals, Inc.	Morgantown	West Virginia
United States	Delaware Neurosurgical Group; Christiana Care Health Systems	Newark	Delaware
United States	Spinal Associates, Gulf Coast Hospital	Panama City	Florida
United States	Allegheny Neurosurgery; Washington Hospital	Pittsburgh	Pennsylvania
United States	Adams Neurosurgery; Mid Michigan Medical Center	Saginaw	Michigan
United States	St. Mary's Spine Center; St. Mary's Hospital	San Francisco	California
United States	Henry Ford Hospital	West Bloomfield	Michigan
United States	Lexington Brain and Spine Institute	West Columbia	South Carolina
United States	Buffalo Neurosurgery Group	West Seneca	New York
United States	Central Ohio Neurological Surgeons; Mt. Carmel East Hospital	Westerville	Ohio
United States	Virginia Brain and Spine; Winchester Medical Center	Winchester	Virginia

Sponsors (1)

Lead Sponsor	Collaborator
Medtronic Spinal and Biologics

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Rate of Overall Success	Rate of overall success is reported as the percentage of participants who met all of the following criteria: Postoperative Neck Disability Index (NDI) score improvement of at least a 15-point increase from preoperative; Maintenance or improvement in neurological status; No serious adverse event classified as implant associated or implant/surgical procedure associated; and; No additional surgical procedure classified as a "failure."	24 Months
Secondary	Success Rate of Neck Disability Index	Success rate of Neck Disability Index is reported as the percentage of participants whose neck disability index score met the following criterion: Pre-treatment Score - Post-treatment Score = 15.	24 months
Secondary	Success Rate of Neurological Status	Success rate of neurological status is reported as the percentage of participants who met neurological success defined as maintenance or improvement in all sections (motor, sensory, and reflexes) for the time period evaluated. In order for a section to be considered a success, each element in the section must either remain the same or improve from the time of the preoperative evaluation to the time period evaluated.	24 months
Secondary	Neck Pain Success Rate	Numerical rating scales were used to evaluate pain intensity and frequency. The pain score (0 min, 20 max) was derived by adding the numerical rating scores from the pain intensity (0-10, with a score of 0 representing "no pain" and a score of 10 representing "pain as bad as it could be.") and frequency scales (0-10, with a score of 0 being "pain none of the time" and a score of 10 being "pain all of the time"). Neck pain success rate is reported as the percentage of participants whose neck pain improvement met the following criterion: Preoperative Score - Postoperative Score > 0.	24 months
Secondary	Arm Pain Success Rate	Numerical rating scales were used to evaluate pain intensity and frequency. The pain score (0 min, 20 max) was derived by adding the numerical rating scores from the pain intensity (0-10, with a score of 0 representing "no pain" and a score of 10 representing "pain as bad as it could be.") and frequency scales (0-10, with a score of 0 being "pain none of the time" and a score of 10 being "pain all of the time"). Arm pain success rate is reported as the percentage of participants whose arm pain improvement met the following criterion: Preoperative Score - Postoperative Score > 0.	24 months
Secondary	Success Rate of SF-36 PCS	Success rate of SF-36 Health Survey include two components: the success rate of a physical component summary (PCS) and the success rate of a mental component summary (MCS). The success of SF-36 PCS was defined as: Post Score - Pre Score >= 0. The Success rate of SF-36 PCS is reported as the percentage of the participants who were classified as a success for SF-36 PCS.	24 months
Secondary	Success Rate of SF-36 MCS	Success rate of SF-36 Health Survey include two components: the success rate of a physical component summary (PCS) and the success rate of a mental component summary (MCS). The success of SF-36 MCS were defined as: Post Score - Pre Score >= 0. The Success rate of SF-36 MCS is reported as the percentage of the participants who were classified as a success for SF-36 MCS.	24 months
Secondary	Rate of Disc Height Success	Disc height was assessed by determining the Functional Spinal Unit (FSU) height. The rate of disc height success is reported as the percentage of participants whose disc height for each level based on either the anterior or posterior measurements met the following criterion: Postoperative Height - 6 Week Postoperative Height >= -2mm	24 months
Secondary	Gait Success Rate	Patient's gait was assessed by using Nurick's classification, and indicated either as normal or graded on a scale of 0 to 5. Success was defined as maintenance or improvement in the postoperative status as compared to the preoperative condition: Preoperative Score - Postoperative Score >= 0. The gait success rate is reported as the percentage of participants who had gait success.	24 months
Secondary	Operative Time	Operative time was recorded from skin incision to wound closure.	Time of operation, an average of 1.7-2.1hrs
Secondary	Blood Loss		During the time of operation, an average of 1.7-2.1 hrs
Secondary	Hospital Stay		From admission to discharge, an average of 1.0-1.5 day
Secondary	Rate of Secondary Surgery at Index Level	Secondary surgical procedures at the index level included revisions, removals, supplemental fixations and reoperations. Rate of secondary surgery at index level is reported as percentage of subjects who had secondary surgeries at index level.	24 months
Secondary	Change of Neck Disability Index Score From Baseline	The self-administered Neck Disability Index (NDI) Questionnaire was used to assess patient neck pain and ability to function. The NDI scale ranges from 0-100. The best score is 0 (no disability) and worst is 100 (maximum disability). Change of NDI was defined as NDI at 24 month minus NDI at baseline.	Baseline and 24 months post-operation
Secondary	Change of Neck Pain Score From Baseline	Numerical rating scales were used to evaluate neck pain intensity and frequency. Subjects rated their neck pain intensity on a scale from 0-10, with a score of 0 representing "no pain" and a score of 10 representing "pain as bad as it could be." Similarly, subjects recorded their neck pain frequency on a scale from 0-10, with a score of 0 being "pain none of the time" and a score of 10 being "pain all of the time." The total neck pain score (0 to 20) was the addition of pain intensity and frequency scores. Change of neck pain score was defined as neck pain score at 24 months minus neck pain score at baseline.	Baseline and 24 months post-operation
Secondary	Change of Arm Pain Score From Baseline	Numerical rating scales were also used to evaluate arm pain intensity and frequency. Subjects rated their arm pain intensity on a scale from 0-10, with a score of 0 representing "no pain" and a score of 10 representing "pain as bad as it could be." Similarly, subjects recorded their arm pain frequency on a scale from 0-10, with a score of 0 being "pain none of the time" and a score of 10 being "pain all of the time." The total arm pain score (0 to 20) was the addition of pain intensity and frequency scores. Change of arm pain score was defined as arm pain score at 24 months minus arm pain score at baseline.	Baseline and 24 months post-operation
Secondary	Change of General Health Status -- SF-36 PCS From Baseline	The Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) was used to assess general health status. The SF-36 results were summarized into two components, a physical component summary (PCS) and a mental component summary (MCS). The score for PCS was between 0 and 100, with higher scores denoting better quality of life. Change of SF-36 PCS score was defined as PCS score at 24 months minus PCS score at baseline.	Baseline and 24 months post-operation
Secondary	Change of General Health Status -- SF-36 MCS From Baseline	The Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) was used to assess general health status. The SF-36 results were summarized into two components, a physical component summary (PCS) and a mental component summary (MCS). The score for MCS was between 0 and 100, with higher scores denoting better quality of life. Change of SF-36 MCS score was defined as MCS score at 24 months minus MCS score at baseline.	Baseline and 24 months post-operation